Get an alert when YOURGENE GENOMIC SERVICES LTD files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-06-11 (in 1mo)

Last made up 2025-05-28

Watchouts

None on the register

Cash

£184K

Latest balance sheet

Net assets

-£4M

lowest in 4 filed years

Employees

9

Average over period

Profit before tax

-£1M

Period ending 2024-12-31

Accounts

4-year trend · latest reflected 2024-12-31

Metric Trend 2021-03-312022-03-312023-12-312024-12-31
Turnover £1,145,000£251,000
Operating profit -£844,000-£800,000
Profit before tax -£899,000-£1,029,000
Net profit -£894,000-£1,029,000
Cash £205,797£88,189£475,000£184,000
Total assets less current liabilities £193,498£190,879-£2,499,000-£3,528,000
Net assets £187,154£187,075-£2,499,000-£3,528,000
Equity £187,154£187,075-£2,499,000-£3,528,000
Average employees 0099
Wages £265,000
Directors' remuneration

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Year-on-year comparison hidden: this filing covers about 12 months versus 9 months prior.

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2021-03-312022-03-312023-12-312024-12-31
Operating margin -73.7%
Net margin -78.1%
Return on capital employed 33.8%22.7%
Gearing (liabilities / total assets) 482.7%1426.3%
Current ratio 0.21x0.07x
Interest cover -15.35x-3.49x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.

Name history

Renamed 1 time since incorporation

  1. YOURGENE GENOMIC SERVICES LTD 2022-04-21 → present
  2. EX5 GENOMICS (UK) LTD 2019-02-01 → 2022-04-21

Audit & accounting basis

Accounting basis
FRS 101
Reporting scope
Standalone (parent only)
Auditor
Constantin
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The directors have, at the time of approving the financial statements, a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis of accounting in preparing the financial statements after having taken into account the available information they have for the future, and especially the cash forecast prepared for the next 12 months.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

2 active · 7 resigned

Name Role Appointed Born Nationality
GIBSON, Steven Michael Director 2023-09-08 Sep 1982 British
REES, Lyn Dafydd Director 2020-07-03 Mar 1973 British
Show 7 resigned officers
Name Role Appointed Resigned
HEXTALL, Barry Secretary 2023-08-29 2023-09-29
DOCHERTY, Paul Trueman Director 2019-02-01 2020-07-03
HEXTALL, Barry Kenneth Director 2023-08-29 2023-09-08
HEXTALL, Barry Kenneth Director 2020-07-03 2023-08-29
KELLY, Jane Director 2019-02-01 2020-07-03
MASON, Joanne Nicola, Dr Director 2023-08-29 2026-05-07
PATEL, Bhavika Director 2019-02-01 2020-07-03

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Yourgene Health Limited Corporate entity Shares 75–100%, Voting 75–100% 2020-07-03 Active
Mr Paul Trueman Docherty Individual Shares 25–50%, Voting 25–50% 2019-02-01 Ceased 2020-07-03
Ms Jane Kelly Individual Shares 25–50%, Voting 25–50% 2019-02-01 Ceased 2020-07-03
Ms Bhavika Patel Individual Shares 25–50%, Voting 25–50% 2019-02-01 Ceased 2020-07-03

Filing timeline

Last 20 of 50 total filings

Date Type Category Description
2026-05-07 TM01 officers Termination director company with name termination date PDF
2025-07-18 AA accounts Accounts with accounts type full
2025-05-30 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-08-25 AA accounts Accounts with accounts type full
2024-06-04 CS01 confirmation-statement Confirmation statement with updates PDF
2024-06-03 PSC05 persons-with-significant-control Change to a person with significant control PDF
2024-01-13 AA accounts Accounts with accounts type audit exemption subsiduary
2024-01-13 PARENT_ACC accounts Legacy
2024-01-13 AGREEMENT2 other Legacy
2024-01-13 GUARANTEE2 other Legacy
2023-11-30 AA01 accounts Change account reference date company current shortened PDF
2023-10-24 MR04 mortgage Mortgage satisfy charge full PDF
2023-09-29 TM02 officers Termination secretary company with name termination date PDF
2023-09-11 AP01 officers Appoint person director company with name date PDF
2023-09-11 TM01 officers Termination director company with name termination date PDF
2023-08-31 AP01 officers Appoint person director company with name date PDF
2023-08-29 TM01 officers Termination director company with name termination date PDF
2023-08-29 AP03 officers Appoint person secretary company with name date PDF
2023-08-29 AP01 officers Appoint person director company with name date PDF
2023-06-08 CS01 confirmation-statement Confirmation statement with no updates PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
3

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page